Cresco Labs Inc.
CL
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -10.15% | -5.73% | -4.53% | -6.43% | -4.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.15% | -5.73% | -4.53% | -6.43% | -4.61% |
| Cost of Revenue | -5.38% | -0.23% | -10.91% | -19.43% | -14.99% |
| Gross Profit | -15.05% | -11.18% | 2.34% | 11.11% | 9.07% |
| SG&A Expenses | 4.28% | 3.45% | -7.35% | -19.83% | -25.45% |
| Depreciation & Amortization | -4.91% | -45.31% | -4.04% | 19.42% | 26.89% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.88% | -1.86% | -9.32% | -18.65% | -18.17% |
| Operating Income | -53.40% | -26.17% | 31.87% | 190.06% | 617.24% |
| Income Before Tax | -105.76% | -76.17% | 109.50% | -38.66% | 244.94% |
| Income Tax Expenses | -20.48% | -67.09% | 430.94% | -26.54% | 7.10% |
| Earnings from Continuing Operations | -641.31% | -90.98% | 93.22% | -17.75% | 92.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 125.56% | -115.45% | -33.85% | -145.50% | -278.19% |
| Net Income | -177.91% | -265.92% | 90.88% | -48.72% | 80.07% |
| EBIT | -53.40% | -26.17% | 31.87% | 190.06% | 617.24% |
| EBITDA | -40.45% | -28.28% | 17.72% | 88.71% | 161.31% |
| EPS Basic | -171.05% | -261.54% | 91.15% | -35.19% | 82.22% |
| Normalized Basic EPS | -94.95% | -147.86% | 23.08% | -1,600.00% | 204.76% |
| EPS Diluted | -171.05% | -261.54% | 91.15% | -35.19% | 82.22% |
| Normalized Diluted EPS | -94.95% | -147.86% | 23.08% | -1,600.00% | 204.76% |
| Average Basic Shares Outstanding | 2.52% | 2.60% | 2.93% | 9.98% | 12.12% |
| Average Diluted Shares Outstanding | 2.52% | 2.60% | 2.93% | 9.98% | 12.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |